Biomedical Research and Therapy http://www.bmrat.org/index.php/BMRAT <div class="slider-container"> <h2>Featured Articles</h2> <div id="myCarousel" class="carousel slide" style="height: 300px; padding: 50px;" data-ride="carousel"><!-- Indicators --> <!-- FEATURED ARTICLES CONTENT HERE --> <div class="carousel-inner"> <div class="item active"><a href="http://www.bmrat.org/index.php/BMRAT/article/view/287">Concise review: Extracellular vesicles from mesenchymal stem cells as cellular therapy </a> <div>Recently, new methods have been developed to isolate and enrich EVs with high performance and low-toxicity. Thus, EVs have emerged as the new generation of stem cell therapy. This concise review aims to highlight some recent achievements of EVs in preclinical and clinical applications.</div> </div> <div class="item"><a href="http://www.bmrat.org/index.php/BMRAT/article/view/198">Association between SNP rs9485372 in TAB2 gene and breast cancer risk 
in Vietnamese women </a> <div>Our finding thus suggested that this SNP is not significantly associated with breast cancer in Vietnamese women. However, the power of this study is quite low at only 4.46% that was partly caused by a small sample size. Hence, a further study needs to be conducted with a larger sample size in the future to confirm the association of this SNP with breast cancer in Vietnamese women.</div> </div> <div class="item"><a href="http://www.bmrat.org/index.php/BMRAT/article/view/178">Up-to-date clinical approaches of biomarkers’ use in heart failure</a> <div>Heart failure (HF) is considered a leading cause of death in patients with established cardiovascular (CV) and metabolic diseases. Although current treatment strategy has improved survival rate and clinical outcomes of HF, the HF prevalence exhibits growth especially in older patients’ population and survivors after coronary atherothrombotic events. Current clinical guidelines regarding treatment and prevention of HF claim the role of biological markers as pretty easy and powerful tool for diagnosis, risk stratification, and prognostication of HF.</div> </div> <div class="item"><a href="http://www.bmrat.org/index.php/BMRAT/article/view/179">Comparative treatment efficiency of adipose and bone marrow derived allogenic mesenchymal stem cell transplantation in mouse models of liver fibrosis </a> <div>After 21 days of transplantation, the results showed that the stem cell treated groups ameliorated better than the placebo group. MSC treated groups showed reduced AST and ALT levels, down-regulated expression of extracellular matrix (ECM) genes, and improved liver histopathology. Both sources of MSCs (bone marrow and adipose tissue) were effective in the mouse model of liver fibrosis.</div> </div> <div class="item"><a href="http://www.bmrat.org/index.php/BMRAT/article/view/182">Determinants of placenta previa: a case-control study </a> <div>The OR of placenta previa was 4.08 (95% CI= 1.44, 11.58) by maternal age, 4.08 (95% CI =1.44, 11.58) by preterm labor, and 6.64 (95% CI =1.09, 40.45) by prior operations of the uterine cavity, compared to normal deliveries and after adjusting for other variables. Multiparity, prior spontaneous abortions, and prior cesarean sections were not statistically significant risk factors for placenta previa, when adjusted for other variables.</div> </div> <div class="item"><a href="http://www.bmrat.org/index.php/BMRAT/article/view/203">Evaluation of Quetiapine Fumarate and its Solid Lipid Nanoparticles as antipsychotic drug in rat model of schizophrenia </a> <div>QFSLN treatment showed enhanced effect over QF in a dose-dependent manner with minimal side effects in schizophrenic rats. In addition, immunohistochemical examinations of brain tissues confirmed the biochemical data.</div> </div> </div> <!-- Left and right controls --> <p><a class="left carousel-control" href="#myCarousel" data-slide="prev"><span class="glyphicon glyphicon-chevron-left"><span style="display: none;">left-arrow</span></span> <span class="sr-only">Previous</span> </a> <a class="right carousel-control" href="#myCarousel" data-slide="next"><span class="glyphicon glyphicon-chevron-right"><span style="display: none;">left-arrow</span></span><span class="sr-only">Next</span> </a></p> </div> </div> en-US <p>Copyright The Author(s) 2017. This article is published with open access by <a href="http://www.biomedpress.org/" target="_blank">BioMedPress</a>. This article is distributed under the terms of the&nbsp;<a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC-BY 4.0)</a> which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.&nbsp;</p> managingeditor@bmrat.org (Lili Hami) support@bmrat.org (Support Team) Fri, 31 Aug 2018 00:00:00 +0000 OJS 3.1.0.1 http://blogs.law.harvard.edu/tech/rss 60